Two Candidates re SARS-2 Origin.
Zhiyan-Le, 2021-04-29.
https://zhiyanleback.blogspot.com/p/two-candidates-re-sars-2-origin.html
https://sites.google.com/site/zhiyanleback/2021-1/z20210429-two-origins
Key Words: Science and research communications, SARS-2, Covid-19.
There are two possible candidates regarding the SARS-2 origin. One is bat
RaTG13, as the WHO-China joint report said. The other is WIV1 series (Wuhan
Institute of Virology, No.1 virus. Totally, it has 8 bat samples, plus WIV16).
The following are key info/data suggesting that RaTG13 is too good to be true as
the SARS-2 origin and that WIV1 is the real origin.
Samples for this essay:
Samples, Raw Data Souce: NIH GenBank. | ||
Name | GenBank ID | Descriptions |
WH-01 | NC_045512.1 | Basic sample, Wuhan patient. |
URL: | https://www.ncbi.nlm.nih.gov/nuccore/NC_045512.1 | |
WIV1 | KF367457.1 | Bat SARS-like coronavirus WIV1, lab product by PRC WIV. |
URL: | https://www.ncbi.nlm.nih.gov/nucleotide/KF367457.1 | |
RaTG13 | MN996532.1 | Bat coronavirus RaTG13, said collected in PRC Yunnan, 2013. |
URL: | https://www.ncbi.nlm.nih.gov/nuccore/MN996532.1 | |
Bat-12 | NC_028824.1 | Bat coronavirus, collected in PRC Yunnan, 2012. |
URL: | https://www.ncbi.nlm.nih.gov/nuccore/971746735 | |
Bat-14 | NC_030886.1 | Bat coronavirus, collected in PRC Yunnan, 2014. |
URL: | https://www.ncbi.nlm.nih.gov/nuccore/NC_030886.1 |
Note: If RaTG13 were really a natural bat sample, its nCov should behave as the
same, or at least very close to, how the other two natural bat samples do.
And here is the alignment on single-gene level:
Global Align re Samples (Raw data and Method: NIH BLAST, by 2021-02) | ||||
Query x Subject | S-Gene | Complete Sequence | ||
Identities | Gaps | Identities | Gaps | |
RaTG13 x NC-045512 | 98% | 0% | 96% | 0% |
RaTG13 x WIV1 | 88% | 2% | 78% | 3% |
RaTG13 x Bat-2012 | 57% | 19% | 55% | 16% |
RaTG13 x Bat-2014 | 61% | 13% | 56% | 12% |
NC-045512 x Bat-2012 | 57% | 19% | 55% | 16% |
NC-045512 x Bat-2014 | 61% | 13% | 56% | 12% |
WIV1 x NC-045512 | 87% | 2% | 78% | 3% |
Taking WH-01(NC_045512) as the basic sample, RaTG13 has highest identities, and
much higher than that of two natural bat sample (2012 and 2014). Question: in
the same location (PRC, Yunnan Province) and in just one year, how come in
nature that the nCov in RaTG13 could be mutated so close to a patient sample
which will be coming over 6.5 years later? However, a lab can do it in 10 days.
And here are similarities on Codon-level:
S-Gene: Codon-Leveled Similarities to NC-045512 | |||||
NC-045512 | WIV1 | RaTG13 | Bat-2012 | Bat-2014 | |
Length by Codon | 1273 | 1260 | 1256 | 1269 | 1132 |
Matching Score | 78 | 693 | 66 | 94 | |
Matching Ratio | 0.0619 | 0.5518 | 0.0520 | 0.0830 | |
ATG | 14 | 17 | 14 | 21 | 29 |
TAA | 0 | 0 | 0 | 0 | 0 |
TAG | 0 | 0 | 0 | 0 | 0 |
TGA | 0 | 0 | 0 | 0 | 0 |
Again, the similarity score of RaTG13 goes much, much higher than that of
natural bat samples and, for the codon ATG, RaTG13 has it exactly as the same as
what the Wuhan patient (NC_045512) has. Is this possible in natural mutations?
Obviously not.
The RaTG13 sample has two versions: one is issued at 2020-03-24 and the new
version is issued at 2020-11-24. And here is their aligned result by NIH Blast:
Alignment of RaTG13: V.1 (2020-03-24) x V.2 (2020-11-24) |
v.1 (2020-03-24): https://www.ncbi.nlm.nih.gov/nuccore/MN996532.1 |
v.2 (2020-11-24): https://www.ncbi.nlm.nih.gov/nuccore/MN996532.2 |
Query Length: 29855 (v.1) |
Subject Length: 29855 (v.2) |
Identities: 29834/29870 (99%) |
Query 1 CTTTCCAGGTAACAAACCAACGAACTCTCGATCTCTTGTAGATCT 45 |
||||||||||||||||||||||||||||||||||||||||||||| |
Sbjct 1 ATTAAAGGTTTATACCTTTCCAGGTAACAAACCAACGAACTCTCGATCTCTTGTAGATCT 60 |
Query 2086 GCTAACAAATATCTTTGGCACTGTCTATGAGCAACTCAAACCTGTTCTTGATTGGCTCGA 2145 |
|||||||||||||||||||||||| |||||| |||||||||||||||||||||||||||| |
Sbjct 2101 GCTAACAAATATCTTTGGCACTGTTTATGAGAAACTCAAACCTGTTCTTGATTGGCTCGA 2160 |
Query 6886 TTCATTTAATTACCTGAAGTCACCTAATTTTTTTACATTGATTAATATTATAATTTGGTT 6945 |
||||||||||||||||||||||||||||||||||| |||||||||||||||||||||||| |
Sbjct 6901 TTCATTTAATTACCTGAAGTCACCTAATTTTTTTAAATTGATTAATATTATAATTTGGTT 6960 |
Query 7066 TACTAATGTCACTACAGCAATCTACTGTACTGGTTCTATACCTTGTGGTGTTTGTCTTAG 7125 |
|||||||||||||||||||||||||||||||||||||||||||||| ||||||||||||| |
Sbjct 7081 TACTAATGTCACTACAGCAATCTACTGTACTGGTTCTATACCTTGTAGTGTTTGTCTTAG 7140 |
Query 29806 GTGATTTTAATAGCTTCTTAGGAGAATGACAAAAAAAAAAAAAAAAAAAA 29855 |
||||||||||||||||||||||||||||||||||| |
Sbjct 29821 GTGATTTTAATAGCTTCTTAGGAGAATGACAAAAA 29855 |
That is blasted on single-gene level. It shows a 99% identity with a few allele
changes and a 15-bp gap (ATTAAAGGTTTATAC). To summarize:
RaTG13 v.1(Ref) and v.2 (Alt): Codon Changes | ||||||||||||||||||
BC | Hidden Codons | BC | Hidden Codon Values | BC-Gain | Total Gain | |||||||||||||
I | II | III | IV | V | VI | I | II | III | IV | V | VI | SUM | ||||||
Ref | CTA | GCA | CGT | TGC | ACA | TGG | TAC | 29 | 37 | 28 | 58 | 5 | 59 | 50 | 266 | 32 | -13 | |
Alt | TTA | AGC | TCG | TAG | CAT | CGG | CTA | 61 | 10 | 55 | 51 | 20 | 27 | 29 | 253 | |||
Ref | GCA | TGA | GTC | CTG | AGA | CTT | CAG | 37 | 57 | 46 | 31 | 9 | 32 | 19 | 231 | -4 | 24 | |
Alt | GAA | GTC | GTC | AGT | CAG | TCA | GTC | 33 | 46 | 46 | 12 | 19 | 53 | 46 | 255 | |||
Ref | TAC | TCG | TGA | AGT | CTC | AGG | ACT | 50 | 55 | 57 | 12 | 30 | 11 | 8 | 223 | -1 | 18 | |
Alt | TAA | TCG | GTC | CTG | AGA | CTT | CAG | 49 | 55 | 46 | 31 | 9 | 32 | 19 | 241 | |||
Ref | TGG | CTA | CTA | ATC | GCG | ATG | CTA | 59 | 29 | 29 | 14 | 39 | 15 | 29 | 214 | -8 | 141 | |
Alt | TAG | TCG | TAC | TCA | GAG | TCC | TGA | 51 | 55 | 50 | 53 | 35 | 54 | 57 | 355 | |||
Ref | CGC | TAC | ATG | TGC | AGG | ACA | CGT | 26 | 50 | 15 | 58 | 11 | 5 | 28 | 193 | 5 | 37 | |
Alt | CTG | GCA | TAC | CAT | GTG | CAA | CGT | 31 | 37 | 50 | 20 | 47 | 17 | 28 | 230 |
In the above, BC refers to Basic Codon, of which each has its own 6 hidden
codons. Hidden codon value refers to energy level corresponding to each codon.
It shows that RaTG13 version 2 gained 207 units on gene-energy-level. Question
is: How could the change and its energy gain naturally happen as the WIV leaders
said that they have genomic sequence without live-sample regarding the bat
RaTG13 nCov?
Regarding the 15-bp gap (ATTAAAGGTTTATAC), here is a comparison:
Assesion | Name | Genomic Data |
NC_045512.1 | WH01-1 | CGGTGACGCATACAA AACATTCCCACCATACCTTCCCAGGTAACAAACCAACCAACTTTCGATCTCTTGT |
NC_045512.2 | WH01-2 | ATTAAAGGTTTATAC CTTCCCAGGTAACAAACCAACCAACTTTCGATCTCTTGTAGATCTGTTCTCTAAA |
MT511081.1 | Poland+ | ATTAAAGGTTTATAC CTTTCCAGGTAACAAACCAACCAACTTTCGATCTCTTGTAGATCTGTTCTCTAAA |
MN996532.1 | RaTG13-1 | CTTTCCAGGTAACAAACCAACGAACTCTCGATCTCTTGTAGATCTGTTCTCTAAA |
MN996532.2 | RaTG13-2 | ATTAAAGGTTTATAC CTTTCCAGGTAACAAACCAACGAACTCTCGATCTCTTGTAGATCTGTTCTCTAAA |
The genomic data comes from each sample (Poland+, NIH Blast-Search result:
hundreds 100% identical samples re patients around the world. Taking the first
one, Poland.).
Question: where does the 15-bp gap come from? How does it go exactly the same
15-bp gap come to both RaTG13 (with no live-sample) and patients around the
world in almost the same time around 2020 autumn?
There is only one convincing answer to the above questions, that is, RaTG13 nCov
is a lab product made for similarities or identities as close as possible to
that of patient samples so as to cover up the real SARS-2 origin, such as WIV1.
Regarding the changes for RaTG13 gene data, here is the relevant info by USRTK:
RATG13: ALTERED DATASETS RAISE MORE QUESTIONS ABOUT RELIABILITY OF KEY STUDIES
ON CORONAVIRUS ORIGINS.
Posted on December 29, 2020.
NO PEER REVIEW FOR ADDENDUM TO PROMINENT CORONAVIRUS ORIGINS STUDY?
Posted on December 18, 2020
URL: https://usrtk.org/tag/ratg13/
It says that, when updating RaTG13 genomic sequence data, the provider, PRC-WIV,
did not give a clear reason, nor did they go through peer-review and other
normal processes.
Speaking of WIV1, its identities (87% to basic sample) should be good enough as
the SARS-2 origin. The provider PRC-WIV said that it is a bat-nCov sample.
However, in international meetings, it was reviewed and approved as a
lab-product. For example:
The University of North Carolina, Institutional Biosafety Committee Meeting Minutes, Jan.09,2019 3:30 PM. Burnett-Womack 9001 |
|
60350 | Infectious clones of bat SARS-like coronaviruses WIV1-CoV and SHC-014 (including reporter-expressing variants) or expressing WIV1 or SHC014 Spike genes - 2019. Renewal |
APPROVED |
Summary: The aim of this study is to generate
reverse genetic infectious clones of bat SARS- like coronaviruses
WIV1-CoV and SHC-014, which are genetically similar to.
Additionally, to determine if the Spike proteins from these viruses are
sufficient to confer infectivity, the Spike
genes from the bat viruses will be introduced into the genome background.
Replication of recombinant viruses
will be monitored through viral passage in cells and infectious of mice. Committee Comments: The proposed containment and safety procedures are adequate for the experimental design. Community Comments: None. III-D, BSL-3, plasmids, mice. |
60351 |
Ralph Baric Transposon mutagenesis of WIV16-CoV to identify genetically flexible regions of CoV genomes |
APPROVED |
Summary: The aim of this experiment is to generate a
transposon mutant library spanning the WIVI6-CoV genome. The
virus library will be screened
in cell culture for viral fitness via passage in cell lines.
Additionally, the screen will be interrogated for genes responsible for
interferon antagonism or RNA replication fidelity. Committee Comments: The proposed containment and safety procedures are adequate for the experimental design. Community Comments: None III-D, BSL-3, plasmids |
Link :: https://2f7nhsvfj5dyz0312njuuj14-wpengine.netdna-ssl.com/wp-content/uploads/2020/08/For-Production-to-Requestor-IBC-Meeting-Minutes.pdf |
In the above re BP genes frequency and distribution on Codon level, WIV1 has the
smallest distance from patient sample (NC_045512), while RaTG13 has three times
bigger distance than that of WIV1 and obviously different from that of natural
samples. See below:
Global Codon BP Freq.Distribution (raw data:NIH GenBank, by 2021-02) | |||||
NC_045512 | WIV1 | RaTG13 | Bat-12 | Bat-14 | |
A | 3038.33 | 2884.67 | 2975.33 | 2342.33 | 2552.33 |
C | 1868.00 | 2020.67 | 1836.67 | 1462.67 | 2135.67 |
G | 1983.67 | 2098.00 | 1948.67 | 1936.00 | 2419.00 |
T | 3267.00 | 3099.67 | 3190.33 | 3250.00 | 2946.00 |
total: | 10157 | 10103 | 9951 | 8991 | 10053 |
avrg: | 2539.25 | 2525.75 | 2487.75 | 2247.75 | 2513.25 |
total gap w NC_045512 | -54 | -206 | -1166 | -104 | |
avrg gap w NC_045512 | -14 | -52 | -292 | -26 |
In more detailed terms, WIV1 and RaTG13 behave the same way:
SARS-2: Global Codon Frequency & Distribution (raw data: NIH GenBank, by 2021-02-22) | |||||||||||||||
NC_045512 | WIV1 | RaTG13 | Bat-12 | Bat-14 | |||||||||||
1st | 2nd | 3rd | 1st | 2nd | 3rd | 1st | 2nd | 3rd | 1st | 2nd | 3rd | 1st | 2nd | 3rd | |
A | 3075 | 2903 | 3137 | 3061 | 2855 | 2738 | 2828 | 3087 | 3011 | 2316 | 2091 | 2620 | 2754 | 2547 | 2356 |
C | 2132 | 1610 | 1862 | 2051 | 2135 | 1876 | 1599 | 1838 | 2073 | 1555 | 1387 | 1446 | 2000 | 2285 | 2122 |
G | 1525 | 1909 | 2517 | 2389 | 1629 | 2276 | 1921 | 2466 | 1459 | 1692 | 1852 | 2264 | 2729 | 2014 | 2514 |
T | 3425 | 3735 | 2641 | 2602 | 3484 | 3213 | 3603 | 2560 | 3408 | 3428 | 3661 | 2661 | 2570 | 3207 | 3061 |
total: | 10157 | 10103 | 9951 | 8991 | 10053 | ||||||||||
avrg: | 2539.25 | 2525.75 | 2487.75 | 2247.75 | 2513.25 | ||||||||||
align w NC_045512: | 0.99468 | 0.97972 | 0.88520 | 0.98976 |
In the above, 1st-2nd-3rd refer to three base genes. In terms of Codons
frequency and distribution, which in fact the virus and ACE2 run and interact
with each other, WIV1 has the highest score, 0.99468, to that of patient sample
(NC_45512), while RaTG13 has clearly lower ration and obviously different from
natural bat samples.
In sum, between the two candidates of SARS-2 origin, WIV1 is the real one;
RaTG13 is not the SARS-2 origin, nor is it a natural sample.
In March 2016, PNAS (publication by US National Academy of Science) published an
article with editor’s notes about the WIV1. Please see:
This Issue, by PNAS March 15, 2016 113 (11) 2793-2795;
https://www.pnas.org/content/113/11/2793
it warned that WIV1 is a lab nCov product, which can directly jump to humans and
cause huge pandemic with global economic loses, can even change existing living
styles. Now the warning is a big reality that the US and the whole world are
facing.
=-=
Comments
Post a Comment